Andrew W. Farrell

Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.

High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 10, 2025

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.

Journal: Molecular cancer

Published: May 23, 2024

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.

Journal: medRxiv : the preprint server for health sciences

Published: March 30, 2023

Correction: TSPAN6 is a suppressor of Ras-driven cancer.

Correction: TSPAN6 is a suppressor of Ras-driven cancer.

Journal: Oncogene

Published: March 16, 2022

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.

Journal: Cancer research

Published: November 22, 2021

TSPAN6 is a suppressor of Ras-driven cancer.

TSPAN6 is a suppressor of Ras-driven cancer.

Journal: Oncogene

Published: December 09, 2020

Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions.

Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions.

Journal: Journal of dermatological science

Published: September 20, 2018

Brm inhibits the proliferative response of keratinocytes and corneal epithelial cells to ultraviolet radiation-induced damage.

Brm inhibits the proliferative response of keratinocytes and corneal epithelial cells to ultraviolet radiation-induced damage.

Journal: PloS one

Published: June 12, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026